119 related articles for article (PubMed ID: 2060026)
1. Promotion of tumor growth by transfecting antisense DNA to suppress endogenous H-2Kk MHC gene expression in AKR mouse thymoma.
Hui KM; Sim BC; Foo TT; Oei AA
Cell Immunol; 1991 Aug; 136(1):80-94. PubMed ID: 2060026
[TBL] [Abstract][Full Text] [Related]
2. Structural variations in the H-2 genes of AKR lymphomas.
Hui K; Minamide L; Prandoni N; Festenstein H; Grosveld FG
J Immunogenet; 1986; 13(2-3):117-21. PubMed ID: 3819448
[TBL] [Abstract][Full Text] [Related]
3. Resistance to cell-mediated cytotoxicity is correlated with reduction of H-2K gene products in AKR leukemia.
Schmidt W; Festenstein H
Immunogenetics; 1982; 16(3):257-64. PubMed ID: 6982849
[TBL] [Abstract][Full Text] [Related]
4. Dominant allele-specific regulation of expression of H-2Kk gene products revealed by somatic cell hybridization.
Bishop CE; Lewis CM; Festenstein H
Somatic Cell Genet; 1982 Sep; 8(5):623-34. PubMed ID: 7135165
[TBL] [Abstract][Full Text] [Related]
5. Introduction of the H-2Dk gene into a class I-negative tumor cell line confers interferon-gamma inducibility upon the silent endogenous H-2Kk gene.
Rosenthal LA; Klyczek KK; Blank KJ
Cell Immunol; 1992 Nov; 145(1):43-55. PubMed ID: 1423645
[TBL] [Abstract][Full Text] [Related]
6. Resistance to cellular immune response in AKR leukemias.
Schäfer A; Schmidt W
Eur J Immunol; 1986 Jul; 16(7):753-9. PubMed ID: 2424771
[TBL] [Abstract][Full Text] [Related]
7. Tumor rejection mediated by transfection with allogeneic class I histocompatibility gene.
Hui KM; Sim T; Foo TT; Oei AA
J Immunol; 1989 Dec; 143(11):3835-43. PubMed ID: 2584720
[TBL] [Abstract][Full Text] [Related]
8. Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation.
Hui K; Grosveld F; Festenstein H
Nature; 1984 Oct 25-31; 311(5988):750-2. PubMed ID: 6333639
[TBL] [Abstract][Full Text] [Related]
9. Interferon sensitive and insensitive MHC variants of a murine thymoma differentially resistant to methotrexate-containing antibody-directed liposomes and immunotoxin.
Machy P; Arnold B; Aliño S; Leserman LD
J Immunol; 1986 Apr; 136(8):3110-5. PubMed ID: 2420883
[TBL] [Abstract][Full Text] [Related]
10. Biochemical analysis of a novel H-2 class I-like glycoprotein expressed in five AKR-(Gross virus) derived spontaneous T cell leukemias.
Labeta MO; Fernandez N; Reyes A; Ferrara P; Marelli O; Le Roy E; Houlihan J; Festenstein H
J Immunol; 1989 Aug; 143(4):1245-53. PubMed ID: 2473124
[TBL] [Abstract][Full Text] [Related]
11. Tumorigenicity of mouse T lymphoma cells is controlled by the level of major histocompatibility complex class I H-2Kk antigens.
VandenDriessche T; Bakkus M; Toussaint-Demylle D; Thielemans K; Verschueren H; De Baetselier P
Clin Exp Metastasis; 1994 Jan; 12(1):73-83. PubMed ID: 8287623
[TBL] [Abstract][Full Text] [Related]
12. Aberrant H-2-like allospecificities on K36.16 thymoma. Studies by radiobinding and immunoprecipitation with anti-H-2 monoclonal antibodies.
Festenstein H; Hui KM
J Immunogenet; 1986; 13(2-3):113-6. PubMed ID: 3819447
[TBL] [Abstract][Full Text] [Related]
13. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. I. Isolation of a selectively resistant variant tumor subclone.
Green WR
Eur J Immunol; 1983 Nov; 13(11):863-70. PubMed ID: 6196206
[TBL] [Abstract][Full Text] [Related]
14. In vitro establishment and some properties of AKR thymoma cell lines.
Riesenfeld I; Tufveson G; Alm GV
Acta Pathol Microbiol Scand A; 1977 Sep; 85(5):739-44. PubMed ID: 303433
[TBL] [Abstract][Full Text] [Related]
15. H-2-specific antibodies induced by injection of syngeneic leukemia cells.
Schmidt W
Immunogenetics; 1987; 25(4):215-21. PubMed ID: 3570375
[TBL] [Abstract][Full Text] [Related]
16. Novel regulation of an MHC class I gene response to interferon-gamma.
Schwarz DA; Buhlmann JE; Kuhne MR; Lam TM; White HD; Green WR
Cell Immunol; 1993 Aug; 150(1):90-100. PubMed ID: 7688271
[TBL] [Abstract][Full Text] [Related]
17. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
18. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
Green WR
J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
[TBL] [Abstract][Full Text] [Related]
19. Aberrant MHC antigens in a sarcoma virus-induced mouse tumour.
Schmidt W; Noll G; Bevec D; Henseling U
J Immunogenet; 1986; 13(2-3):123-32. PubMed ID: 3029231
[TBL] [Abstract][Full Text] [Related]
20. H-2 class I heavy chain and B2-microglobulin are coordinately synthesized in studies of AKR thymomas.
Alonzo AD; Festenstein H; Schmidt W
Transplant Proc; 1983 Dec; 15(4):2021-3. PubMed ID: 6424288
[No Abstract] [Full Text] [Related]
[Next] [New Search]
